Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis A Randomized Clinical Trial ++++

Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis A Randomized Clinical Trial https://jamanetwork.com/journals/jama/article-abstract/2816236?utm_campaign=morning_rounds&utm_medium=email&_hsmi=298983789&_hsenc=p2ANqtz-9jgcGdldbTPUIQE2oc2MPqb7qBN-GNGu49QvJuoutzKDe7tbQGgxyaES34BSvsow8hEjWr9M1WU4Vhpj8fwU9ev5K8lQ&utm_content=298983789&utm_source=hs_email Renamed, common liver diseases might get fairer shake at treatment, researchers hope Isabella Cueto By Isabella Cueto Dec. 28, 2023 https://www.statnews.com/2023/12/28/liver-disease-masld-nafld-mash-nash-metald/?utm_campaign=morning_rounds&utm_medium=email&_hsmi=298983789&_hsenc=p2ANqtz--aSHVGmSgA9yjeh5Lr6msLxmLm6RkMbmHs33IQUoWUvnAtOSjgpRmlunfCUD3LHQPkSktLnpydD0TXFtzvAH2etFgCNg&utm_content=298983789&utm_source=hs_email Madrigal wins first U.S. approval for drug to treat liver disease MASH Adam Feuerstein By Adam Feuerstein March 14, 2024 https://www.statnews.com/2024/03/14/madrigal-mash-drug-approval/?utm_campaign=morning_rounds&utm_medium=email&_hsmi=298983789&_hsenc=p2ANqtz--KpUT-TE1vRHkTA2ea9JqXI7BxsTEUT0pJXpwamA9GbxCpl662x8Z4P4UT1n7eVwRZDq2Mf2i4QWh-HytC-g5kynh61Q&utm_content=298983789&utm_source=hs_email In small study, baby aspirin cuts fat buildup in liver disease patients Isabella Cueto By Isabella Cueto March 19, 2024 https://www.statnews.com/2024/03/19/baby-aspirin-liver-disease-masld/?utm_campaign=morning_rounds&utm_medium=email&_hsmi=298983789&_hsenc=p2ANqtz-8Q4-OlUvcS2f6vmGWhy81yFEATh9I82rMfcP4C0d5UtFeiB8eMAtQCDcsiEe6-Um527z41MapyhUovvSpZdxl2UsnYAA&utm_content=298983789&utm_source=hs_email